Fresenius Medical Care AG (FMS) Liabilities and Shareholders Equity (2009 - 2025)

Fresenius Medical Care AG's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $36.1 billion for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 0.61% year-over-year to $36.1 billion; the TTM figure through Dec 2025 stood at $142.1 billion (down 2.29% YoY), while the FY2025 annual figure was $36.1 billion, up 0.61% from the prior year.
• Liabilities and Shareholders Equity was $36.1 billion for Q4 2025 at Fresenius Medical Care AG, roughly flat from $36.1 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $40.0 billion in Q1 2021 to a low of $43.7 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $33.7 billion across 5 years, with a median of $36.9 billion in 2023.
• The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity tumbled 74.21% in 2021, then jumped 83516.35% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $58.0 million in 2021, then declined by 24.69% to $43.7 million in 2022, then surged by 83516.35% to $36.5 billion in 2023, then dropped by 1.74% to $35.9 billion in 2024, then rose by 0.61% to $36.1 billion in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $36.1 billion (Q4 2025), $36.1 billion (Q3 2025), and $35.4 billion (Q2 2025), per Business Quant data.